Aberrant RP11-296E3.2 expression impairs YBX1 function, and leads to reduced STAT3 transcription, translation and phosphorylation, thus inhibiting the proliferation and metastasis of CRC cells. This evidence concerns the gene STAT3 and colorectal carcinoma.